AKORN INC | 11,187 Euro | +0,025 +0,22 % | |
| WKN: 888920 ISIN: US0097281069 Ticker-Symbol: FDA | Frankfurt | 20.05.13 | 15:32 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 20.05. | Post Earnings Update: Akorn Has Climbed 3.4% Higher in Past Week | - | SmarTrend | |
| 16.05. | Akorn - Gap-Close würde Potenzial versprechen | 1 | GodmodeTrader.de | |
| 07.05. | Vitamin Shoppe, Fossil, Akorn are big movers | 2 | Yahoo-USA | |
| 07.05. | Akorn's CEO Discusses Q1 2013 Results - Earnings Call Transcript | 1 | Seeking Alpha | |
| 07.05. | Why Akorn Shares Were Crushed | 2 | Motley Fool | |
| 07.05. | Akorn Falling Today on Above-Average Volume | - | SmarTrend | |
| 07.05. | Shares of Akorn Under Pressure, Down 10.9% | - | SmarTrend | |
| 07.05. | AKORN INC - 8-K, Current Report | - | SEC Filings | |
| 07.05. | Akorn Reports Higher Q1 Profit | 82 | AFX News | |
| WASHINGTON (dpa-AFX) - Akorn Inc. (AKRX, AKRN.OB), a niche generic
pharmaceutical company, posted a surge in GAAP net income to $10.84 million, or
$0.10 a share, from $3.11 million, or $0.03... Mehr lesen zu: Akorn Reports Higher Q1 Profit | ||||
| 08.04. | Mylan, Akorn, Astex Pharma, and Forest Laboratories Under StockCall's Microscope | 54 | PR Newswire | |
| LONDON, April 8, 2013 /PRNewswire/ --
A major trend to emerge in the healthcare industry since last year has been the expiration of patents on several blockbuster drugs. The trend has benefited companies... Mehr lesen zu: Mylan, Akorn, Astex Pharma, and Forest Laboratories Under StockCall's Microscope | ||||
| 03.04. | Akorn, Inc. Announces First Quarter 2013 Earnings Release And Conference Call Information | 49 | PR Newswire | |
| LAKE FOREST, Ill., April 3, 2013 /PRNewswire/ --Akorn, Inc. (NASDAQ: AKRX) will host a conference callonTuesday, May 7, 2013, to discuss first quarter 2013 results followedbya Q&A session. Thecompany... Mehr lesen zu: Akorn, Inc. Announces First Quarter 2013 Earnings Release And Conference Call Information | ||||
| 14.03. | Akorn - Achten Sie auf den Wochenschlusskurs | 4 | GodmodeTrader.de | |
| 08.03. | Before the Bell Scans of Mylan, Forest Laboratories, Avanir Pharma, Akorn, and Medicines Co. | 62 | PR Newswire | |
| LONDON, March 8, 2013 /PRNewswire/ --
The U.S. Supreme Court last year upheld President Obama's Affordable Care Act (ACA). The ACA is the biggest overhaul of the healthcare industry in decades. While... Mehr lesen zu: Before the Bell Scans of Mylan, Forest Laboratories, Avanir Pharma, Akorn, and Medicines Co. | ||||
| 05.03. | The Prescription of Success: Improving Pipelines, Increasing Capabilities - Research Report on Globus, Akorn, Anika, Orthofix and Sangamo Biosciences | 108 | PR Newswire | |
| NEW YORK, March 5, 2013 /PRNewswire/ --
Today, Investors Alliance announced new research reports highlighting Globus Medical Inc (NYSE: GMED), Akorn, Inc. (NASDAQ: AKRX), Anika Therapeutics, Inc.... Mehr lesen zu: The Prescription of Success: Improving Pipelines, Increasing Capabilities - Research Report on Globus, Akorn, Anika, Orthofix and Sangamo Biosciences | ||||
| 26.02. | Akorn's CEO Discusses Q4 2012 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 26.02. | Akorn Q4 Profit Climbs, Tops Estimates | 43 | AFX News | |
| WASHINGTON (dpa-AFX) - Akorn Inc. (AKRX), a manufacturer of diagnostic and
therapeutic ophthalmic pharmaceuticals, reported Tuesday a higher profit for its
fourth-quarter on increased sales... Mehr lesen zu: Akorn Q4 Profit Climbs, Tops Estimates | ||||
| 25.02. | Earnings Update: Akorn Releases its Quarterly Earnings on February 26th, 2013 | - | SmarTrend | |
| 05.02. | Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information | 30 | PR Newswire | |
| LAKE FOREST, Ill., Feb.5, 2013 /PRNewswire/ --Akorn, Inc. (NASDAQ: AKRX) will host a conference callon Tuesday, February 26, 2013, to discuss fourth quarter and year-end 2012 results followedbya Q&A... Mehr lesen zu: Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information | ||||
| 31.01. | Possible Bullish Inside Day Candle Pattern Detected for Akorn | - | SmarTrend | |
| 29.01. | Akorn - Ausbruch gilt als gescheitert | 5 | GodmodeTrader.de | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| CORTEX PHARMACEUTICALS | 0,009 | -52,63 % | XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-014 |
| ARYX THERAPEUTICS | 0,004 | +100 % | XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-013 |
| ALEXZA PHARMACEUTICALS | 3,406 | +0,24 % | Alexza Reports 2013 First Quarter Financial Results |
| K-V PHARMACEUTICAL | 0,188 | -6 % | KV PHARMACEUTICAL CO /DE/ - 8-K, Current Report |
| SINCLAIR IS PHARMA | 0,311 | +1,63 % | Sinclair IS Pharma Disposes Fazol G For EUR 1.15 Mln |
